Table 4.
Characteristics of the death cases after receipt of COVID-19 vaccines.
| Characteristics | Number of reports (n = 1,919 [%]) | Percentage of the total AEs reports | |
|---|---|---|---|
| Gender | Male | 1,039 (54.1) | 2.3 |
| Female | 840 (43.7) | 1.8 | |
| Unspecified | 40 (2.1) | 0.08 | |
| History (Allergies) | No | 1,444 (75.2) | 3.2 |
| Yes | 475 (24.7) | 1.0 | |
| History of chronic disease | Cardiovascular disease (CVD) | 737 (38.4) | 1.6 |
| Respiratory disease | 251 (13.0) | 0.56 | |
| Diabetes | 312 (16.2) | 0.7 | |
| Renal disease | 187 (9.7) | 0.4 | |
| Vaccine brand name | Pfizer-BioNTech | 899 (46.8) | 2.0 |
| Moderna | 997 (50.9) | 2.2 | |
| Janssen Ad26.COV2.S | 16 (0.8) | 0.03 | |
| Unspecified | 7 (0.4) | 0.01 | |